UroGen Pharma Ltd. (LON:0XOD)
London flag London · Delayed Price · Currency is GBP · Price in USD
14.31
-0.18 (-1.24%)
At close: Jul 11, 2025

UroGen Pharma Market Cap

UroGen Pharma has a market cap or net worth of 486.40 million as of July 11, 2025. Its market cap has increased by 3.46% in one year.

Market Cap
486.40M
Enterprise Value
431.55M
Revenue
71.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.31

Market Cap Chart

Since May 4, 2017, UroGen Pharma's market cap has increased from 129.71M to 486.40M, an increase of 275.00%. That is a compound annual growth rate of 17.51%.

History

DateMarket Cap% Change
Jul 11, 2025 486.40M 35.49%
Dec 31, 2024 358.99M -1.24%
Dec 29, 2023 363.49M 113.84%
Dec 30, 2022 169.98M 7.95%
Dec 31, 2021 157.47M -46.00%
Dec 31, 2020 291.60M -44.84%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 162.05B
HSBC Holdings 158.16B
Shell 157.53B
Unilever 111.66B
British American Tobacco p.l.c. 82.86B
Rolls-Royce Holdings 82.44B
Rio Tinto Group 75.96B
RELX PLC 72.94B
Market Cap Rankings